J&J | JNJ - Operating Profit


J&J reported $6.62B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Abbott USD 1.85B 399M Mar/2026
Amgen USD 3.83B 130M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Biogen USD 514.3M 128.8M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
CONMED USD 25.42M 11.21M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teva Pharmaceutical Industries USD 758M 271M Mar/2026
Vertex Pharmaceuticals USD 1.14B 124.5M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026
Zoetis USD 865M 30M Mar/2026